{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:08:55Z","timestamp":1788307735455,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.vaccine.2006.12.044","type":"journal-article","created":{"date-parts":[[2007,1,6]],"date-time":"2007-01-06T07:11:07Z","timestamp":1168067467000},"page":"3428-3436","source":"Crossref","is-referenced-by-count":5,"title":["A comparative assessment of immunization records in the Defense Medical Surveillance System and the Vaccine Adverse Event Reporting System"],"prefix":"10.1016","volume":"25","author":[{"given":"Michael M.","family":"McNeil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Aranas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Charles E.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.12.044_bib1","unstructured":"Medical readiness: safety and efficacy of the anthrax vaccine (GAO\/T-NSAID-99-148). Washington, DC: United States General Accounting Office; October 1999."},{"key":"10.1016\/j.vaccine.2006.12.044_bib2","unstructured":"Honner WK, Ryan MAK, Aran R, Clemons A, Campbell KM, Smith TC, et al. The U.S. military immunization database: quality of data on anthrax immunizations in military women, 1998\u20132000. In: Presented at the fourth registry conference, Atlanta, GA, October 27\u201329, 2003."},{"key":"10.1016\/j.vaccine.2006.12.044_bib3","series-title":"Immunizations and chemoprophylaxis\u2014Army Regulation 40-562 (Air Force Joint Instruction 48-110; Bureau of Medicine Instruction 6230.15; Coast Guard Commandant Instruction M6230.4E)","author":"Department of the Army","year":"1995"},{"key":"10.1016\/j.vaccine.2006.12.044_bib4","series-title":"Memorandum to Surgeon General of the Army, Surgeon General of the Navy and Surgeon General of the Air Force","article-title":"Policy for reporting adverse events associated with the anthrax vaccine","author":"Bailey","year":"1999"},{"issue":"12","key":"10.1016\/j.vaccine.2006.12.044_bib5","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.2105\/AJPH.92.12.1900","article-title":"The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance","volume":"92","author":"Rubertone","year":"2002","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.vaccine.2006.12.044_bib6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0264-410X(94)90315-8","article-title":"The Vaccine Adverse Event Reporting System (VAERS)","volume":"12","author":"Chen","year":"1994","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2006.12.044_bib7","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/S0264-410X(99)00132-2","article-title":"An overview of the Vaccine Adverse Event Reporting System (VAERS) as a surveillance system","volume":"17","author":"Singleton","year":"1999","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.044_bib8","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001. CDC surveillance summaries (January 24)","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR"},{"issue":"4","key":"10.1016\/j.vaccine.2006.12.044_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety: information from the Vaccine Adverse Event Reporting System (VAERS)","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2006.12.044_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3928\/0090-4481-20040901-11","article-title":"The role of the Vaccine Adverse Event Reporting System (VAERS) in monitoring vaccine safety","volume":"33","author":"Iskander","year":"2004","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.vaccine.2006.12.044_bib11","unstructured":"Code of Federal Regulations. 21 CFR 600.80. Revised on April 1; 2002."},{"key":"10.1016\/j.vaccine.2006.12.044_bib12","unstructured":"National Childhood Vaccine Injury Act of 1986 at Section 2125 of the Public Health Service Act as codified at 42 U.S.C. Section 300aa-26."},{"key":"10.1016\/j.vaccine.2006.12.044_bib13","series-title":"The anthrax vaccine: is it safe? Does it work?","year":"2002"},{"key":"10.1016\/j.vaccine.2006.12.044_bib14","series-title":"Memorandum to Commanders of the North Atlantic, Southeast, Great Plains, Western, European and Pacific Regional Medical Commands","article-title":"Reactions to vaccines","author":"Peake","year":"2000"},{"key":"10.1016\/j.vaccine.2006.12.044_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/pds.1213","article-title":"Development of the vaccine analytic unit's research agenda for investigating potential adverse events associated with anthrax vaccine adsorbed","volume":"16","author":"Payne","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.044_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/oxfordjournals.aje.a009785","article-title":"Quality of HMO immunization databases used to monitor childhood vaccine safety. Vaccine Safety DataLink Team","volume":"149","author":"Mullooly","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2006.12.044_bib17","unstructured":"Biological products: bacterial vaccines and toxoids; implementation of efficacy review; anthrax vaccine adsorbed; final order. Federal Register 2005;70:75180\u201398."},{"key":"10.1016\/j.vaccine.2006.12.044_bib18","unstructured":"FDA Issues Final Order\u2014AVA safe and effective, protects individuals at high risk for anthrax diseases DOD AVIP to continue under current EUA rules and conditions until further notice. Anthrax Vaccine Immunization Program. www.anthrax.mil\/EUA [accessed on March 27; 2006]."},{"issue":"12","key":"10.1016\/j.vaccine.2006.12.044_bib19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/pds.936","article-title":"Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)","volume":"13","author":"Sever","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2006.12.044_bib20","unstructured":"Payne DC, Rose Jr. CE, Aranas A, Zhang Y, Tolentino H, Weston E, et al. Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998\u20132004. Pharmacoepidemiol Drug Saf, submitted for publication."},{"issue":"5","key":"10.1016\/j.vaccine.2006.12.044_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00002018-200629050-00002","article-title":"Data mining in the US using the Vaccine Adverse Event Reporting System","volume":"29","author":"Iskander","year":"2006","journal-title":"Drug Saf"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06013843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06013843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:58:02Z","timestamp":1547081882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06013843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":21,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0264410X06013843"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.12.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}